29 results
ARS
2023 FY
MYGN
Myriad Genetics, Inc.
17 Apr 24
Annual report to shareholders
4:33pm
also formed an internal Environmental, Social, and Governance (ESG) Committee in an effort to develop and maintain sustainable business practices … , and sustainable presence in our international markets; difficulty in staffing and managing foreign operations; managing multiple payor reimbursement
8-K
EX-99.1
MYGN
Myriad Genetics, Inc.
6 Nov 23
Results of Operations and Financial Condition
4:05pm
credit facility. We remain confident in our ability to achieve our goal of adjusted profitability by the fourth quarter 2023 and sustainable 10 … profitability by the fourth quarter of 2023 and sustainable 10%+ annual revenue growth, and that the new breast cancer risk assessment program with Onsite Women's
8-K
MYGN
Myriad Genetics, Inc.
6 Nov 23
Results of Operations and Financial Condition
4:05pm
of 2023 and sustainable 10%+ annual revenue growth, and that the new breast cancer risk assessment program with Onsite Women's Health is expected to enable
8-K
gzgx7ej
3 Aug 23
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.1
zplxx
3 Aug 23
Results of Operations and Financial Condition
4:05pm
8-K
6w87p7navq9qzb 3o
3 May 23
Results of Operations and Financial Condition
4:06pm
8-K
EX-99.1
vmebxl1v0aklt prob
3 May 23
Results of Operations and Financial Condition
4:06pm
ARS
02zz4dcwn6ts8a6 f5
12 Apr 23
Annual report to shareholders
4:10pm
8-K
EX-99.1
bk6uahvbqb21s90
1 Nov 22
Myriad Genetics Reports Third Quarter Financial Results
9:03am
8-K
EX-99.1
prhr nbq944wmr
11 Jan 22
Results of Operations and Financial Condition
4:16pm
8-K
EX-99.1
mfa4j
2 Nov 21
Continues Strong Execution of Strategic Growth & Transformation Plans
8:40am
8-K
EX-99.1
ygmd26in bl0zt0a
3 Aug 21
Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Strategic Growth & Transformation Plans
7:05am